Lipodystrophy syndrome in HIV-infected children on HAART
Lipodystrophy Syndrome (LD) is common in HIV-infected children, particularly in those taking Didanosine, Stavudine, or Zidovudine. Lipoatrophy in particular causes major stigmatization and interferes with adherence. In addition, LD may have significant long-term health consequences, particularly car...
Saved in:
Main Authors: | Steve Innes (Author), Leon Levin (Author), Mark Cotton (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2009-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cavitation of the Ghon focus in an HIV-infected infant who acquired tuberculosis after the initiation of HAART
by: S. Innes, et al.
Published: (2009) -
Treating HIV-infected children
by: Mark Cotton, et al.
Published: (2009) -
A rare phenomenon of atypical lipodystrophy in a patient on HAART in the absence of a protease inhibitor regimen
by: Mohammed Mitha, et al.
Published: (2010) -
Biochemical Manifestation of HIV Lipodystrophy Syndrome
by: Kenneth Ihenetu, PhD, et al.
Published: (2016) -
Biochemical Manifestation of HIV Lipodystrophy Syndrome
by: Kenneth Ihenetu, PhD, et al.
Published: (2012)